Literature DB >> 535182

The association of cryoglobulinaemia with nodules, vasculitis and fibrosing alveolitis in rheumatoid arthritis and their relationship to serum C1q binding activity and rheumatoid factor.

C C Erhardt, P Mumford, R N Maini.   

Abstract

Two measurements of serum immune complexes, cryoglobulinaemia and 125I-C1q binding, have been performed in patients with severe rheumatoid arthritis (RA) and compared with normal levels. Cryoglobulinaemia was present in 20 out of 28 patients (71%) with extra-articular disease (mean level 17 micrograms/ml) including nodules, digital vasculitis, cutaneous ulcers, rash, neuropathy, lung disease and scleritis, but in none of 32 patients with joint disease alone (uncomplicated RA) (mean level 3 micrograms/ml). Cryoglobulinaemia correlates with, but probably does not antedate, extra-articular disease, and may be useful in predicting morbidity and mortailty in this group of patients. In contrast, serum 125I-Clq binding was raised in patients with uncomplicated RA and those with extra-articular disease, although levels were higher in the latter group. Both tests showed a negative correlation with serum haemolytic complement and a positive correlation with IgM rheumatoid factor although there were some sera with raised levels of rheumatoid factor without cryoglobulinaemia. These results suggest that cryoglobulinaemia is a better test than Clq-binding for demonstrating the presence of circulating immune complexes involved in the pathogenesis of extra-articular lesions.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 535182      PMCID: PMC1537919     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  20 in total

1.  STANDARDIZATION OF THE SHEEP CELL AGGLUTINATION TEST. THE USE OF POOLED REFERENCE SERA AND HEMAGGLUTINATION TRAYS.

Authors:  E S CATHCART; J B O'SULLIVAN
Journal:  Arthritis Rheum       Date:  1965-08

2.  Possible relationship of rheumatoid factors and pulmonary disease.

Authors:  T B TOMASI; H H FUDENBERG; N FINBY
Journal:  Am J Med       Date:  1962-08       Impact factor: 4.965

3.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

4.  Rheumatoid hyperviscosity syndrome.

Authors:  H E Jasin; J LoSpalluto; M Ziff
Journal:  Am J Med       Date:  1970-10       Impact factor: 4.965

5.  Direct evidence for circulating DNA/anti-DNA complexes in systemic lupus erythematosus.

Authors:  J S Davis; S M Godfrey; J B Winfield
Journal:  Arthritis Rheum       Date:  1978 Jan-Feb

6.  The molecular basis of self-association of antibodies to IgG (rheumatoid factors) in rheumatoid arthritis.

Authors:  R M Pope; D C Teller; M Mannik
Journal:  Proc Natl Acad Sci U S A       Date:  1974-02       Impact factor: 11.205

7.  Circulating immune complexes in the idiopathic interstitial pneumonias.

Authors:  R B Dreisin; M I Schwarz; A N Theofilopoulos; R E Stanford
Journal:  N Engl J Med       Date:  1978-02-16       Impact factor: 91.245

8.  A clinical and pathological study of sixteen cases of rheumatoid arthritis with extensive visceral involvement ('rheumatoid disease').

Authors:  B CRUICKSHANK; R J SINCLAIR
Journal:  Q J Med       Date:  1956-07

9.  Circulating complement breakdown products in patients with rheumatoid arthritis. Correlation between plasma C3d, circulating immune complexes, and clinical activity.

Authors:  U E Nydegger; R H Zubler; R Gabay; G Joliat; C H Karagevrekis; P H Lambert; P A Miescher
Journal:  J Clin Invest       Date:  1977-05       Impact factor: 14.808

10.  An unusual protein component of high molecular weight in the serum of certain patients with rheumatoid arthritis.

Authors:  E C FRANKLIN; H R HOLMAN; H J MULLER-EBERHARD; H G KUNKEL
Journal:  J Exp Med       Date:  1957-05-01       Impact factor: 14.307

View more
  17 in total

1.  Circulating immune complexes and rheumatoid arthritis: a comparison of different assay methods and their early predictive value for disease activity and outcome.

Authors:  J S Reeback; A J Silman; E J Holborow; R N Maini; F C Hay
Journal:  Ann Rheum Dis       Date:  1985-02       Impact factor: 19.103

2.  Rheumatoid vasculitis.

Authors:  D G Scott; P A Bacon
Journal:  Clin Rheumatol       Date:  1983-12       Impact factor: 2.980

3.  Cryoglobulins in cases of rheumatoid arthritis.

Authors:  D Chattopadhya; B Ravindran; K Prakash
Journal:  Rheumatol Int       Date:  1985       Impact factor: 2.631

4.  IgG rheumatoid factor, complement and immune complexes in rheumatoid synovitis and vasculitis: comparative and serial studies during cytotoxic therapy.

Authors:  D G Scott; P A Bacon; C Allen; C J Elson; T Wallington
Journal:  Clin Exp Immunol       Date:  1981-01       Impact factor: 4.330

5.  Circulating immune complexes in polymyalgia rheumatica and giant cell arteritis.

Authors:  J R Park; J G Jones; G D Harkiss; B L Hazleman
Journal:  Ann Rheum Dis       Date:  1981-08       Impact factor: 19.103

6.  Differences in immunochemical characteristics of cryoglobulins in rheumatoid arthritis and systemic lupus erythematosus and their complement binding properties.

Authors:  C C Erhardt; P Mumford; R N Maini
Journal:  Ann Rheum Dis       Date:  1984-06       Impact factor: 19.103

7.  Pathogenic significance of serum components in the development of autoimmune polyarthritis in MRL/Mp mice bearing the lymphoproliferation gene.

Authors:  J Itoh; M Nose; M Kyogoku
Journal:  Am J Pathol       Date:  1991-09       Impact factor: 4.307

8.  IgE and IgE-rheumatoid factors in circulating immune complexes in rheumatoid arthritis.

Authors:  K Meretey; A Falus; C C Erhardt; R N Maini
Journal:  Ann Rheum Dis       Date:  1982-08       Impact factor: 19.103

9.  Detection and partial characterization of immune complexes in patients with rheumatoid arthritis plus Sjogren's syndrome and with Sjogren's syndrome alone.

Authors:  S Yoshinoya; S McDuffy; D Alarcon-Segovia; R M Pope
Journal:  Clin Exp Immunol       Date:  1982-05       Impact factor: 4.330

10.  The complement fixing ability of putative circulating immune complexes in rheumatoid arthritis and its relationship to extra-articular disease.

Authors:  B E Bourke; I K Moss; P Mumford; A Horsfall; R N Maini
Journal:  Clin Exp Immunol       Date:  1982-06       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.